Title:
PHARMACEUTICAL COMPOSITION FOR INTRAOCULAR OR ORAL ADMINISTRATION FOR TREATMENT OF RETINAL DISEASES
Document Type and Number:
WIPO Patent Application WO/2020/145364
Kind Code:
A1
Abstract:
The present invention provides: a pharmaceutical composition that is to be intraocularly or orally administered for preventing or treating a retinal disease (e.g., age-related macular degeneration) of a patient who needs to be treated, or inhibiting the progression of the disease, and that contains a pharmaceutically-acceptable carrier and an effective amount of at least one compound selected from the group consisting of apomorphine, eseroline, ethoxyquin, methyldopa, olanzapine, indapamide, and the like; and a method.
More Like This:
Inventors:
YAMADA KEN-ICHI (JP)
SHINDOU SAKI (JP)
ISHIDA MINATO (JP)
YAMAMOTO KEIICHI (JP)
SHINDOU SAKI (JP)
ISHIDA MINATO (JP)
YAMAMOTO KEIICHI (JP)
Application Number:
PCT/JP2020/000538
Publication Date:
July 16, 2020
Filing Date:
January 09, 2020
Export Citation:
Assignee:
YAMADA KEN ICHI (JP)
FUSO PHARMACEUTICAL IND (JP)
FUSO PHARMACEUTICAL IND (JP)
International Classes:
A61K31/137; A61K9/06; A61K9/08; A61K9/20; A61K31/403; A61K31/407; A61K31/47; A61P27/02
Domestic Patent References:
| WO2015029948A1 | 2015-03-05 | |||
| WO2019009355A1 | 2019-01-10 |
Foreign References:
| JP2007515422A | 2007-06-14 | |||
| JP2012506410A | 2012-03-15 | |||
| JP2011520788A | 2011-07-21 | |||
| JP2018025496W | 2018-07-05 |
Other References:
ACAR, N. ET AL., PLOSS. ONE, vol. 7, 2012, pages 35102
YE.X. ET AL., TRENDS. MOL. MED., vol. 16, 2010, pages 417 - 25
TANITO M. ET AL., INVEST. OPHTHALMOL. VIS. SCI., vol. 48, no. 4, 2007, pages 1900 - 5
See also references of EP 3919052A4
YE.X. ET AL., TRENDS. MOL. MED., vol. 16, 2010, pages 417 - 25
TANITO M. ET AL., INVEST. OPHTHALMOL. VIS. SCI., vol. 48, no. 4, 2007, pages 1900 - 5
See also references of EP 3919052A4
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: